Astellas partners with universities for neglected tropical diseases

Astellas Pharma Inc. (Tokyo:4503) announced separate deals on Thursday with two Japanese universities

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE